Rajan Sharma analyst GOLDMAN SACHS

Currently out of the existing stock ratings of Rajan Sharma, 5 are a HOLD (23.81%), 11 are a BUY (52.38%), 5 are a SELL (23.81%).

Rajan Sharma

Work Performance Price Targets & Ratings Chart

Analyst Rajan Sharma, currently employed at GOLDMAN SACHS, has had 41.67% of price targets met with an average potential upside of 64.38%, reached in 137 days on average. Previously, Rajan Sharma worked at DEUTSCHE BANK.

Rajan Sharma has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DBVT, DBV Technologies at 09-Apr-2026.

Wall Street Analyst Rajan Sharma

Analyst best performing recommendations are on MOR (MORPHOSYS AG ADR).
The best stock recommendation documented was for MOR (MORPHOSYS AG ADR) on 11/22/2023. The price target of $19.13 was fulfilled within 176 days with a profit of $14.58 (320.44%), with a performance score of 18.21.

Average potential price target upside

AZN AstraZeneca PLC ADR DBVT DBV Technologies IMCR Immunocore Holdings Ltd MOR MorphoSys AG ADR ARGX argenx NV ADR HCM HUTCHMED DRC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Dec-2019

$240

$55.55 (30.12%)

$105

7 months 21 days ago
(30-Mar-2026)

12/15 (80%)

$47.4 (24.61%)

572

Buy Since 27-Jan-2020

$220

$35.55 (19.27%)

$174

7 months 24 days ago
(27-Mar-2026)

5/16 (31.25%)

$32.82 (17.53%)

570

Buy Since 11-Apr-2023

$109

$-75.45 (-40.91%)

$168

8 months 18 days ago
(02-Mar-2026)

1/3 (33.33%)

$-93.39 (-46.14%)

128

Buy Since 26-Jan-2018

$108.5

$-75.95 (-41.18%)

11 months 26 days ago
(25-Nov-2025)

6/7 (85.71%)

$-74.82 (-40.81%)

856

Hold Since 27-Oct-2025

1 years 24 days ago
(27-Oct-2025)

2/3 (66.67%)

$-6.12 (-4.81%)

958

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Rajan Sharma?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?